Biotech & Research Commercial Strategy
D’Angelo Advisory partners with biotech, research, and scientific platform companies to translate complex innovation into focused commercial execution. With over a decade of experience at the intersection of proteomics, data platforms, and life sciences commercialization, I work with founders and leadership teams to clarify positioning, refine go-to-market strategy, and build scalable revenue systems. From early-stage market validation to enterprise sales strategy and partnership development, my approach blends scientific fluency with structured commercial discipline, helping ambitious science organizations grow with precision and purpose.
Reserve an appointment
If you are navigating growth, refining your commercial strategy, or evaluating new market opportunities, I welcome a conversation. Schedule a brief introductory conversation to discuss your objectives and explore how D’Angelo Advisory can support your next phase of growth
The D’Angelo Advisory
company ethos
Science Deserves Commercial Rigor
Scientific innovation requires commercial systems as thoughtful and disciplined as the research itself. Strategy should clarify complexity, not oversimplify it.
Precision Over Noise
Growth is not built on volume alone. It is built on disciplined positioning, defined processes, and intentional market engagement. We prioritize clarity, structure, and measurable progress.
Long-Term Alignment
Sustainable commercial growth requires alignment between scientific value, market need, and organizational capability. Quick wins matter, but durable architecture matters more.
Partnership, Not Transaction
Advisory work is collaborative. I work alongside leadership teams as a strategic partner, bringing candid insight and structured thinking to critical decisions.
Integrity in Execution
Commercial strategy shapes trajectory. It should be grounded in honesty, data, and respect for the scientific community it serves.
